Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial.
This phase 2 trial assessed the combination of transarterial chemoembolization (TACE) with atezolizumab and bevacizumab...